Does inhibition of miR-320a prevent doxorubicin-induced cardiotoxicity?
Inhibition of miR-320a
Doxorubicin-induced cardiotoxicity
Inhibition of miR-320a may serve as a potential therapeutic strategy for treating anthracycline-induced cardiac dysfunction.
Our observations demonstrate that miR-320a play important roles in doxorubicin induced cardiotoxicity via vessel homeostasis in heart and thus, inhibition of miR-320a may be applied to the treatment of cardiac dysfunction induced by anthracycline.
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhongwei Yin
Yanru Zhao
Huaping Li
Aging
Huazhong University of Science and Technology
Tongji Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Yin et al. (Sat,) studied this question.
www.synapsesocial.com/papers/69dff587ca6b6a2615860502 — DOI: https://doi.org/10.18632/aging.100876
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: